Andrographolid Sulfonatein

· Qingfeng Pharmaceutical Group

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Andrographolid Sulfonatein, covering 2018-04-10 to 2018-04-10. Get the full timeline:

Most recent: Clinical Trial Update: Adjunctive Therapy of Andrographolid Sulfonatein Community Acquired Pneumonia [Phase 4]